Dr. Peter McLoughlin
Funded Investigator Medicine
I have been involved with SSPC as a Funded Investigator since its inception. My research is composed of both formulation/drug delivery and the development of high value added products from natural sources. A key emphasis of my research has been engagement with pharmaceutical companies to support innovation. A number of successful research projects have been completed with industry partners with case studies available on www.pmbrc.org.
A large number of these projects involved synthesis and characterisation of pharmaceutical formulations incorporating polymeric components. I am the PI of the PMBRC, an Enterprise Ireland Technology Gateway and Head of the School of Science and Computing at WIT. To date I have supervised 22 PhD students to completion with research topics incorporating smart delivery systems and pharmaceutical processing.
- API excipient interactions
- Non-invasive drug delivery methods
- Pharmaceutical characterisation
- Molecular Imprinting
- Analytical Science
 Elsiddig R, Hughes H, Owens E, O’ Reilly N J, O’Grady D, McLoughlin P, “Kinetic and thermodynamic evaluation of phosphate ions binding onto sevelamer hydrochloride”, Int. J. of Pharmaceutics, 474, 25-32, (2014)
 Weiss C, McLoughlin P, and Cathcart H, “Characterisation of dry powder inhalation formulations using atomic force microscopy”, Int. J. of Pharmaceutics, 494, 393-407, (2015)
 Behl G.; Iqbal J.; O’Reilly N.; McLoughlin P.; Fitzhenry L T., Pharmaceutical Research, “Synthesis and characterization of poly(2-hydroxyethylmethacrylate) contact lenses containing chitosan nanoparticles as an ocular delivery system for dexamethasone sodium phosphate”, 33, 7, 1638-1648 (2016)
 Dillon C, Hughes H, O’Reilly N J, and McLoughlin P, Int. J. of Pharmaceutics, “Formulation and characterisation of dissolving microneedles for the transdermal delivery of therapeutic peptides”, 526, 1–2, 125–136, (2017)
 Weiss C., Mcloughlin P., Manesiotis P., Redington W., Cathcart H., “Preparation and Characterization of Beclomethasone Dipropionate Solvates”, Crystal Growth & Design, 18 (10), 5832-5844 (2018).